Is CUBXF or MRK a better dividend investment in 2026?

CUBXF currently yields 10000.00% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: CUBXF offers higher current income.

What is the dividend yield difference between CUBXF and MRK?

CUBXF has a forward dividend yield of 10000.00% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 9997.24 percentage points.

Home › Compare › CUBXF vs MRK

CUBXF vs MRK: Dividend Comparison 2026

CUBXF yields 10000.00% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CUBXF wins by $55137509079256512.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CUBXF

● Live price

10000.00%

Share price

$0.02

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$55137509079256512.00M

Annual income

$54,073,795,673,722,890,000,000.00

Full CUBXF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — CUBXF vs MRK

📍 CUBXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CUBXF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CUBXF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CUBXF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CUBXF

Annual income on $10K today (after 15% tax)

$850,000.00/yr

After 10yr DRIP, annual income (after tax)

$45,962,726,322,664,450,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, CUBXF beats the other by $45,962,726,322,664,450,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CUBXF + MRK for your $10,000?

CUBXF: 50%MRK: 50%

100% MRK50/50100% CUBXF

Portfolio after 10yr

$27568754539628256.00M

Annual income

$27,036,897,836,861,443,000,000.00/yr

Blended yield

98.07%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CUBXF

No analyst data

Altman Z

-13.7

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CUBXF buys

MRK buys

No recent congressional trades found for CUBXF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCUBXFMRK

Forward yield	10000.00% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$55137509079256512.00M ✓	$56.8K
Annual income after 10y	$54,073,795,673,722,890,000,000.00 ✓	$9,798.13
Total dividends collected	$55066727460582336.00M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CUBXF vs MRK ($10,000, DRIP)

Year	CUBXF Portfolio	CUBXF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$1,010,700	$1,000,000.00	$11,206	$366.19	+$999.5K → CUBXF
2	$95,539,393	$94,457,943.93	$12,650	$502.35	+$95.53M → CUBXF
3	$8,447,007,736	$8,344,780,585.66	$14,407	$694.19	+$8446.99M → CUBXF
4	$698,565,746,383	$689,527,448,105.17	$16,585	$967.82	+$698565.73M → CUBXF
5	$54,040,711,670,213	$53,293,246,321,583.74	$19,342	$1,363.89	+$54040711.65M → CUBXF
6	$3,910,851,616,519,516	$3,853,028,055,032,387.00	$22,913	$1,947.19	+$3910851616.50M → CUBXF
7	$264,781,167,546,477,440	$260,596,556,316,801,570.00	$27,662	$2,823.89	+$264781167546.45M → CUBXF
8	$16,772,556,223,821,672,000	$16,489,240,374,546,942,000.00	$34,159	$4,173.35	+$16772556223821.64M → CUBXF
9	$994,124,678,068,810,000,000	$976,178,042,909,320,800,000.00	$43,337	$6,308.80	+$994124678068810.00M → CUBXF
10	$55,137,509,079,256,515,000,000	$54,073,795,673,722,890,000,000.00	$56,776	$9,798.13	+$55137509079256512.00M → CUBXF

CUBXF vs MRK: Complete Analysis 2026

CUBXF — Stock

CubicFarm Systems Corp. develops, manufactures, and sells cubic farming systems for farmers worldwide. The company offers CubicFarm System and CubicFarms' HydroGreen Grow System. Its systems help farmers to produce lettuce, basil, microgreens, nutraceutical ingredients, and animal feed. The company was formerly known as Forty Foot Farms Ltd. and changed its name to CubicFarms Systems Corp. in June 2016. CubicFarms Systems Corp was incorporated in 2015 and is headquartered in Langley, Canada.

Full CUBXF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this CUBXF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CUBXF vs SCHD CUBXF vs JEPI CUBXF vs O CUBXF vs KO CUBXF vs MAIN CUBXF vs JNJ CUBXF vs ABBV CUBXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.